Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute, 10390 [2022-03900]
Download as PDF
<![CDATA[
10390
Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1140–NEW]
Agency Information Collection
Activities; Proposed eCollection of
eComments Requested; New
Collection; Request for Temporary
Eligibility To Hold a Sensitive
Position—ATF Form 8620.69
[Docket No. DEA–955]
Bulk Manufacturer of Controlled
Substances Application: Scottsdale
Research Institute
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 30-Day notice.
AGENCY:
Notice of application.
Scottsdale Research Institute,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 25, 2022. Such persons
may also file a written request for a
hearing on the application on or before
April 25, 2022.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2022,
Scottsdale Research Institute, 5436 East
Tapekim Road, Cave Creek, Arizona
85331, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7437
7438
I
I
jspears on DSK121TN23PROD with NOTICES1
The company plans to bulk
manufacture the listed controlled
substances for clinical trials. No other
activities for these drug codes are
authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–03900 Filed 2–23–22; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:46 Feb 23, 2022
Overview of This Information
Collection
Jkt 256001
The Bureau of Alcohol,
Tobacco, Firearms and Explosives
(ATF), Department of Justice (DOJ) will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until March 28, 2022.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and, if so, how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 9990
(1) Type of Information Collection:
New Collection.
(2) The Title of the Form/Collection:
Request for Temporary Eligibility to
Hold a Sensitive Position.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: ATF Form 8620.69.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals or households.
Other: None.
Abstract: The Request for Temporary
Eligibility to Hold a Sensitive Position—
ATF Form 8620.69 will be used to
determine if a candidate for Federal or
contractor employment at the Bureau of
Alcohol, Tobacco, Firearms and
Explosives can be granted a temporary
eligibility to hold a sensitive position
prior to the completion and
adjudication their full background
investigation.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 2,000
respondents will respond to this
collection once annually, and it will
take each respondent approximately 5
minutes to complete their responses.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
167 hours, which is equal to 2,000 (total
respondents) * 1 (# of response per
respondent) * .833333 (5 minutes or the
time taken to prepare each response).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Mail Stop 3.E–
405A, Washington, DC 20530.
Dated: February 18, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2022–03941 Filed 2–23–22; 8:45 am]
BILLING CODE 4410–FY–P
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03900]
[[Page 10390]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-955]
Bulk Manufacturer of Controlled Substances Application:
Scottsdale Research Institute
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Scottsdale Research Institute, has applied to be registered as
a bulk manufacturer of basic class(es) of controlled substance(s).
Refer to Supplemental Information listed below for further drug
information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 25, 2022.
Such persons may also file a written request for a hearing on the
application on or before April 25, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2022, Scottsdale Research Institute, 5436
East Tapekim Road, Cave Creek, Arizona 85331, applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for clinical trials. No other activities for these drug
codes are authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-03900 Filed 2-23-22; 8:45 am]
BILLING CODE P
